Novartis AG Cash Flow Quality Index
Novartis AG cash flow quality index. Novartis AG (NVSN) has a Cash Flow Quality Index of 1.16x as of March 2026. Operating cash flow of MX$3.68 Billion exceeds net income of MX$3.16 Billion, indicating high earnings quality where cash backs reported profits. See Novartis AG free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Novartis AG (2014–2025)
Cash flow quality index of Novartis AG from 2014 to 2025. Historical Cash Flow Quality Index for Novartis AG across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Novartis AG to assess how comfortably operating cash covers total debt obligations.
Novartis AG Cash Flow Quality Index by Year (2014–2025)
Novartis AG cash flow quality index by year from 2014 to 2025. Year-by-year earnings quality comparison for Novartis AG. For the full cash flow conversion analysis, see NVSN cash flow conversion.
| Year | Quality Index | Operating CF (MXN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | MX$19.14 Billion | MX$13.98 Billion | ▼ -7.2% |
| 2024 | 1.48x | MX$17.62 Billion | MX$11.94 Billion | ▲ +36.8% |
| 2023 | 1.08x | MX$16.02 Billion | MX$14.85 Billion | ▼ -47.3% |
| 2022 | 2.05x | MX$14.24 Billion | MX$6.96 Billion | ▲ +226.2% |
| 2021 | 0.63x | MX$15.07 Billion | MX$24.02 Billion | ▼ -62.9% |
| 2020 | 1.69x | MX$13.65 Billion | MX$8.07 Billion | ▲ +45.6% |
| 2019 | 1.16x | MX$13.62 Billion | MX$11.73 Billion | ▲ +2.6% |
| 2018 | 1.13x | MX$14.27 Billion | MX$12.61 Billion | ▼ -30.9% |
| 2017 | 1.64x | MX$12.62 Billion | MX$7.70 Billion | ▼ -4.2% |
| 2016 | 1.71x | MX$11.47 Billion | MX$6.71 Billion | ▲ +155.5% |
| 2015 | 0.67x | MX$11.90 Billion | MX$17.78 Billion | ▼ -50.8% |
| 2014 | 1.36x | MX$13.90 Billion | MX$10.21 Billion | — |